Intravenous immunoglobulin therapy
Nakada, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 6): 527-531
2016
ISSN/ISBN: 0047-1852 PMID: 30547555 Document Number: 689247
Document emailed within 1 workday
Related Documents
Ishii, N.; Hashimoto, T. 2010: Intravenous immunoglobulin (TVIG) therapy in pemphigus Nihon Rinsho. Japanese Journal of Clinical Medicine 68(11): 2143-2146Komoly, S.ám. 2014: Intravenous immunoglobulin therapy in neuroimmunological disorders Ideggyogyaszati Szemle 67(7-8): 281-282
Llombart, M.; García-Abujeta, J.L.; Sánchez-Pérez, R.M.; Hernando de Larramendi, C. 2007: Pompholyx induced by intravenous immunoglobulin therapy Journal of Investigational Allergology and Clinical Immunology 17(4): 277-278
Pasatiempo, A.M.; Kroser, J.A.; Rudnick, M.; Hoffman, B.I. 1994: Acute renal failure after intravenous immunoglobulin therapy Journal of Rheumatology 21(2): 347-349
Uyttendaele, H.; Obadiah, J.; Grossman, M. 2003: Dyshidrotic-like spongiotic dermatitis after intravenous immunoglobulin therapy Journal of Drugs in Dermatology: Jdd 2(3): 337-341
Hashkes, P.J.; Lovell, D.J. 1996: Vasculitis in systemic lupus erythematosus following intravenous immunoglobulin therapy Clinical and Experimental Rheumatology 14(6): 673-675
De Sanctis, J.T.; Cumbo-Nacheli, G.; Dobbie, D.; Baumgartner, D. 2008: HIV-associated nemaline rod myopathy: role of intravenous immunoglobulin therapy in two persons with HIV/AIDS Aids Reader 18(2): 90-94
Chu, C.C.; Huang, C.C. 1996: Low-dose intravenous immunoglobulin therapy in myasthenia gravis: a case report Zhonghua Yi Xue Za Zhi 57(3): 232-235
Wojtecka, A.; Kade, G.; Bilbin-Bukowska, A.; Niemczyk, S.ła. 2012: Acute kidney injury (AKI) requireing renal replacement therapy in a patient treated with intravenous immunoglobulin Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 32(189): 173-175
Sciascia, S.; Giachino, O.; Roccatello, D. 2012: Prevention of thrombosis relapse in antiphospholipid syndrome patients refractory to conventional therapy using intravenous immunoglobulin Clinical and Experimental Rheumatology 30(3): 409-413
Jordan, S.C.; Vo, A.A.; Nast, C.C.; Tyan, D. 2003: Use of high-dose human intravenous immunoglobulin therapy in sensitized patients awaiting transplantation: the Cedars-Sinai experience Clinical Transplants 2003: 193-198
Shaĭkov, A.V.; Kuznetsova, I.O.; Movsisian, G.R. 1998: Intravenous immunoglobulin in combined therapy for children with juvenile rheumatoid arthritis (evaluation of therapeutical efficiency and factors that influence them) Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 12: 36-39
Garbett, N.D.; Currie, D.C.; Cole, P.J. 1989: Comparison of the clinical efficacy and safety of an intramuscular and an intravenous immunoglobulin preparation for replacement therapy in idiopathic adult onset panhypogammaglobulinaemia Clinical and Experimental Immunology 76(1): 1-7
Börner, P.; Deicher, H.; Bähr, I.; Chalius, H.H.; Ghani, G.; Geldmacher, H.; Henke, I.W.; Kindermann, L.; Marks, V. 1976: Prophylatic rhesus sensitization via intravenous administration of immunoglobulin G anti-D. III. Limits of the prophylaxsis obtainable by adapting the immunoglobulin dosage to the extent of the fetalmaternal blood transfusion Geburtshilfe und Frauenheilkunde 36(6): 485-492
Whimbey, E.; Champlin, R.E.; Englund, J.A.; Mirza, N.Q.; Piedra, P.A.; Goodrich, J.M.; Przepiorka, D.; Luna, M.A.; Morice, R.C.; Neumann, J.L. 1995: Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients Bone Marrow Transplantation 16(3): 393-399
Jordan, S.C.; Quartel, A.W.; Czer, L.S.; Admon, D.; Chen, G.; Fishbein, M.C.; Schwieger, J.; Steiner, R.W.; Davis, C.; Tyan, D.B. 1998: Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action Transplantation 66(6): 800-805
Alfonso, J.; Gralla, J.; Klem, P.; Chan, L.; Wiseman, A.C.; Cooper, J.E. 2014: High-Dose Intravenous Immunoglobulin Therapy for Donor Specific Antibodies in Kidney Transplant Recipients with Acute and Chronic Graft Dysfunction: Updates on Previously Reported Cohorts Clinical Transplants 2014: 161-170
Davis, M.J.; Dawes, P.T.; Beswick, E.; Lewin, I.V.; Stanworth, D.R. 1989: Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin British Journal of Rheumatology 28(5): 410-413
Ventura, A.; Florean, P.; Pascone, R.; Perini, R.; Pocecco, M.; Lepore, L. 1986: Intravenous immunoglobulin in immune neutropenia Helvetica Paediatrica Acta 41(6): 495-500
Walsh, J.J. 1974: Studies on the purification of normal immunoglobulin for intravenous use Developments in Biological Standardization 27: 31-36